Physician profile
Bryan D Maxwell
NPI 1477521482
$2,818.49
in general payments reported to CMS, 2019-2025
12 companies · $49.70 in 2025
The $49.70 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,275 · 2020: $32.32 · 2021: $260 · 2022: $52.25 · 2023: $56.64 · 2024: $93.41 · 2025: $49.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $199.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,513.85 | 2019-2024 | |
| Medtronic USA, INC. | $865.10 | 2019 | |
| Abbvie INC. | $134.77 | 2019-2023 | |
| Becton, Dickinson and Company | $65.30 | 2019-2025 | Arista |
| Coopersurgical, INC. | $48.88 | 2021 | |
| Organon LLC | $46.29 | 2021-2023 | Nexplanon |
| Pfizer INC. | $38.49 | 2019 | |
| Novo Nordisk INC | $26.38 | 2019 | |
| Merck Sharp & Dohme LLC | $26.23 | 2019 | |
| Urovant Sciences INC | $22.14 | 2022 | |
| Allergan, INC. | $18.32 | 2019 | |
| Mycovia Pharmaceuticals, INC. | $12.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Maxwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.